Advancing Infectious Diseases Diagnostic Testing and Applications to Antimicrobial Therapy in the ICU. (June 2019)

• Record Type: Journal Article
• Authors: Lam, Simon W.; Bass, Stephanie N.
• Is Part Of: Journal of pharmacy practice. Volume 32:Number 3(2019:Jun.)
• Page Start: 327
• Page End: 338
• Publication Date: 2019-06
• Subjects: infectious diseases -- rapid diagnostic tests -- critical care; Pharmacy -- Periodicals; Pharmacology -- Periodicals; 615.1
• DOI: 10.1177/0897190019831162
• Languages: English
• ISSNs: 0897-1900

Abstract

Treatment of suspected infections in critically ill patients requires the timely initiation of appropriate antimicrobials and rapid de-escalation of unnecessary broad-spectrum coverage. New advances in rapid diagnostic tests can now offer earlier detection of pathogen and potential resistance mechanisms within hours of initial culture growth. These technologies, combined with pharmacist antimicrobial stewardship efforts, may result in shorten time to adequate coverage or earlier de-escalation of unnecessary broad spectrum antimicrobials, which could improve patient outcomes and lower overall treatment cost. Furthermore, de-escalation of antimicrobials may lead to decreased emergence of resistant organisms and adverse events associated with antimicrobials. Clinical pharmacists should be aware of new rapid diagnostic tests, including their application, clinical evidence, and limitations, in order to implement the most appropriate clinical treatment strategy when patients have positive cultures. This review will focus on commercially available rapid diagnostic tests for infections that are routinely encountered by critically ill patients, including gram-positive and gram-negative bacterial blood stream infections, Candida, and Clostridioides difficile .